Inhalational Drug Devices: Revisiting the Linchpin of Asthma Management-Reference-Cited by-同舟云学术

Inhalational Drug Devices: Revisiting the Linchpin of Asthma Management

Published:2024-08-16 Issue:8 Volume:14 Page:867
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Saxena Damini¹^ORCID,Murugesan Neveda¹,Evbayiro Uyioghosa D.²,Ngassa Marina K.²,Adrish Muhammad¹^ORCID

Affiliation:

1. Baylor College of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, 1 Baylor Plz, Houston, TX 77030, USA

2. Baylor College of Medicine, Section of General Internal Medicine, 1 Baylor Plz, Houston, TX 77030, USA

Abstract

Asthma remains a prevalent condition among all age groups globally. First-line treatment requires the delivery of medications into the distal respiratory tract via inhalers. Using appropriate inhaler techniques is a significant challenge in achieving disease control. A variety of inhalers are available for treating asthma, and selecting the appropriate inhaler type for any given patient is crucial to achieving and maintaining symptomatic control. This review will discuss the anatomy and physiology behind drug delivery via inhalers, the types of inhalers currently available for use, nebulizers, and future directions in the delivery of inhaled medications for asthma.

Publisher

MDPI AG

Link

https://www.mdpi.com/2075-4426/14/8/867/pdf

Reference47 articles.

1. (2024, June 21). US Centers for Disease Control and Prevention (24 July 2023). AsthmaStats. CDC.gov, Available online: https://www.cdc.gov/asthma/asthma_stats/default.htm.

2. GBD 2019 Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204–1222.

3. Global Initiative for Asthma (2024, June 20). Global Strategy for Asthma Management and Prevention. Available online: https://www.ginasthma.org.

4. Asthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: A retrospective analysis;Levy;Prim. Care Respir. J.,2013

5. What can be done to impact respiratory inhaler use: Exploring the problem, reasons, and solutions;Volerman;Expert. Rev. Respir. Med.,2020